Inventor · disambiguated record
Volker Schulze
Also filed as: SCHULZE VOLKER · SCHULZE VOLKER K
21 granted patents·24 pending applications·29 citations·filing 2003–2024
90Inventor score
Top patents by PatentIndex Score
45 records- 0186US7511059B2Thiazolidinones, their production and use as pharmaceutical agentsBAYER SCHERING PHARMA AG·Filed 2006·Granted Mar 31, 2009·14 cites·15 claims
- 0280US9670202B2Substituted triazolopyridinesBayer Pharma AG·Filed 2014·Granted Jun 6, 2017·2 cites·16 claims
- 0378US10266548B2Substituted benzylindazoles for use as Bub1 kinase inhibitors in the treatment of hyperproliferative diseasesBAYER IP GMBH·Filed 2017·Granted Apr 23, 2019·2 cites·2 claims
- 0477US10428063B24H-pyrrolo[3,2-C]pyridin-4-one derivativesBayer Pharma AG·Filed 2016·Granted Oct 1, 2019·3 cites·15 claims
- 0575US9409889B2Amino-substituted imidazopyridazinesBayer Pharma AG·Filed 2013·Granted Aug 9, 2016·3 cites·9 claims
- 0674US12227501B23-amino-2-[2-(acylamino)pyridin-4-yl]-1,5,6,7-tetrahydro-4h-pyrrolo[3,2-c]pyridin-4-one as CSNK1 inhibitorsBAYER AG·Filed 2020·Granted Feb 18, 2025·1 cites·15 claims
- 0774US11339157B14H-pyrrolo[3,2-c]pyridin-4-one derivativesBAYER AG·Filed 2018·Granted May 24, 2022·2 cites·19 claims
- 0871US2025136599A14h-pyrrolo[3,2-c]pyridin-4-one compoundsBAYER AG·Filed 2024·Application pending·0 cites
- 0965US9663510B2Substituted triazolopyridines and their use as TTK inhibitorsBAYER IP GMBH·Filed 2012·Granted May 30, 2017·1 cites·27 claims
- 1064US10604532B2Substituted benzylindazoles for use as BUB1 kinase inhibitors in the treatment of hyperproliferative diseasesBAYER IP GMBH·Filed 2019·Granted Mar 31, 2020·0 cites·6 claims
- 1163US8551980B2Substituted triazolopyridinesSCHULZE VOLKER·Filed 2010·Granted Oct 8, 2013·1 cites·13 claims
- 1260US2023416249A1N-[2-({4-[3-(anilino)-4-oxo-4,5,6,7-tetrahydro-1h-pyrrolo[3,2-c]pyridin-2-yl]pyridin-3-yl)oxy)ethyl]prop-2-enamide derivatives and similar compounds as egfr inhibitors for the treatment of cancerBAYER AG·Filed 2023·Application pending·0 cites
- 1358US2025154170A1Fused pyrimidines as kras inhibitorsBAYER AG·Filed 2023·Application pending·0 cites
- 1456US2023064983A13-(anilino)-2-[3-(3-alkoxy-pyridin-4-yl]-1,5,6,7-tetrahydro-4h-pyrrolo[3,2-c]pyridin-4-one derivatives as egfr inhibitors for the treatment of cancerBAYER AG·Filed 2022·Application pending·0 cites
- 1554US2025188075A1Substituted heterocyclic csnk1 inhibitorsBROAD INST INC·Filed 2023·Application pending·0 cites
- 1654US2022298157A14h-pyrrolo[3,2-c]pyridin-4-one compoundsBAYER AG·Filed 2020·Application pending·0 cites
- 1752US2014249133A1Substituted benzylindazoles for use as bub1 kinase inhibitors in the treatment of hyperproliferative diseasesBAYER IP GMBH·Filed 2012·Application pending·0 cites
- 1849US2023365554A1Substituted pyrrolo-pyridinone derivatives and therapeutic uses thereofBROAD INST INC·Filed 2021·Application pending·0 cites
- 1948US2023322767A1Aryl substituted pyrrolo-pyridinones and therapeutic uses thereofBAYER AG·Filed 2021·Application pending·0 cites
- 2047US2023391769A1Substituted heterocyclic compounds and therapeutic uses thereofBAYER AG·Filed 2021·Application pending·0 cites
- 2146US2024307362A14H-PYRROLO[3,2-c]PYRIDIN-4-ONE COMPOUNDSBAYER AG·Filed 2020·Application pending·0 cites
- 2246US2007015759A1Metasubstituted thiazolidinones, their manufacture and use as a drugSCHULZE VOLKER K·Filed 2005·Application pending·0 cites
- 2345US2007037862A1Thiazolidinones, their production and use as pharmaceutical agentsSIEMEISTER GERHARD·Filed 2004·Application pending·0 cites
- 2444US9586958B2Prodrug derivatives of substituted triazolopyridinesBayer Pharma AG·Filed 2014·Granted Mar 7, 2017·0 cites·14 claims
- 2544US9388177B2Method for preparing substituted triazolopyridinesBayer Pharma AG·Filed 2013·Granted Jul 12, 2016·0 cites·3 claims
- 2644US2016207928A1Novel compounds for the treatment of cancerBayer Pharma AG·Filed 2014·Application pending·0 cites
- 2743US9783543B2AminoimidazopyridazinesBayer Pharma AG·Filed 2013·Granted Oct 10, 2017·0 cites·8 claims
- 2843US9745304B2Amidoimidazopyridazines as MKNK-1 kinase inhibitorsBayer Pharma AG·Filed 2014·Granted Aug 29, 2017·0 cites·9 claims
- 2943US2016272635A1Substituted dihydropyrido[3,4-b]pyrazinones as dual inhibitors of bet proteins and polo-like kinasesBayer Pharma AG·Filed 2014·Application pending·0 cites
- 3043US2006079503A1Thiazolidinones and the use therof as polo-like kinase inhibitorsSCHERING AG·Filed 2003·Application pending·0 cites
- 3142US9777004B2Amino-substituted imidazopyridazinesBAYER IP GMBH·Filed 2013·Granted Oct 3, 2017·0 cites·9 claims
- 3242US2016264568A1Substituted triazolopyridines having activity as mps-1 inhibitorsBayer Pharma AG·Filed 2014·Application pending·0 cites
- 3342US2021047297A14-(3-amino-6-fluoro-1h-indazol-5-yl)-1,2,6-trimethyl-1,4-dihydropyridine-3,5-dic arbonitrile compounds for treating hyperproliferative disordersBayer Pharma AG·Filed 2019·Application pending·0 cites
- 3441US9643974B2Amino-substituted imidazopyridazinesBAYER IP GMBH·Filed 2012·Granted May 9, 2017·0 cites·9 claims
- 3540US10894784B2Heteroarylbenzimidazole compoundsBayer Pharma AG·Filed 2016·Granted Jan 19, 2021·0 cites·15 claims
- 3637US2014120087A1TriazolopyridinesSCHULZE VOLKER·Filed 2012·Application pending·0 cites
- 3737US2016120854A1Pharmaceutical compositionsBAYER PHARMA AKTIENGESELl SCHAFT·Filed 2014·Application pending·0 cites
- 3837US2007010565A1New thiazolidinones without basic nitrogen, their production and use as pharmaceutical agentsPRIEN OLAF·Filed 2006·Application pending·0 cites
- 3936US2017342064A1Compounds for the treatment of cancerBayer Pharma AG·Filed 2015·Application pending·0 cites
- 4035US10214545B2Amido-substituted imidazopyridazines useful in the treatment of hyper-proliferative and/or angiogenesis disordersBayer Pharma AG·Filed 2015·Granted Feb 26, 2019·0 cites·21 claims
- 4134US9676766B2TriazolopyridinesSCHULZE VOLKER·Filed 2010·Granted Jun 13, 2017·0 cites·14 claims
- 4234US9555022B2Substituted triazolopyridinesSCHULZE VOLKER·Filed 2011·Granted Jan 31, 2017·0 cites·15 claims
- 4334US2007010566A1Thiazolidinones without basic nitrogen, their production and use as pharmaceutical agentsPRIEN OLAF·Filed 2006·Application pending·0 cites
- 4433US10428044B23-amino-1,5,6,7-tetrahydro-4H-indol-4-onesBayer Pharma AG·Filed 2015·Granted Oct 1, 2019·0 cites·13 claims
- 4533US2013121994A1Triazolopyridine derivativesKOPPITZ MARCUS·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Volker Schulze files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →